Organovo ' s Drug Significantly Reduces Liver Fat in NASH Study Organovo ' s Drug Significantly Reduces Liver Fat in NASH Study

Organovo Holdings ' experimental drug reduced liver fat by as much as 22.8% in a mid-stage study of some patients with non-alcoholic steatohepatitis (NASH), fueling optimism...Reuters Health Information
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Gastroenterology News Source Type: news